Lecture on Anticoagulants: Heparin, Warfarin, and Others

Overview

• Main Focus: Comparing and contrasting heparin, warfarin, and other anticoagulants.
• Additional Topics: Brief discussion on Lovenox, Eliquis, and Xarelto in relation to anticoagulation.

Heparin

• Type: Unfractionated heparin
• Administration: Can be given subcutaneously (sub-Q) or intravenously (IV).
• Indications:
  • Deep vein thrombosis (DVT)
  • Heart attack (thrombosis-related)
• Function: Stabilizes clots to allow the body time to manage or until further therapy is given.
• Action in Clotting Cascade: Acts on specific clotting factors.
• Monitoring Test: Partial Thromboplastin Time (PTT).

Warfarin

• Action: Affects multiple clotting factors across the clotting cascade.
• Danger/Risks:
  • Highly effective yet dangerous due to varying patient responses.
  • Each person's unique physiology results in different lab values for the same dose.
  • Monitoring is essential to prevent adverse effects.
• Cost: Cheap, making it accessible but often used out of necessity due to cost constraints.
• Monitoring Test: Prothrombin Time (PT) and International Normalized Ratio (INR).

Lovenox (Low Molecular Weight Heparin)

• Action: Targets a single clotting factor.

Modern Anticoagulants

• Examples: Eliquis, Xarelto
• Mechanism: Similar to Lovenox, these medications affect one clotting factor.
• Benefit: Reduced need for extensive blood testing.

Conclusion

• Importance of Understanding: Knowledge of how these drugs work and their testing is crucial for safe patient management.

Note: The lecture suggests a focus on the practical implications and safety concerns associated with using these anticoagulants.